Select Page

Latest News

September 15, 2021
Rapid Dose Therapeutics and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones

August 26, 2021
Rapid Dose Therapeutics Reports Q1 Financial Results and Exercise of Warrant for Net Proceeds of $689,000

August 26, 2021
Rapid Dose Therapeutics Reports Fiscal Year 2021 Financial Results

August 10, 2021
Rapid Dose Provides Bi-Weekly Status Report Regarding Management Cease Trade Order

July 30, 2021
RAPID DOSE THERAPEUTICS ANNOUNCES GRANT OF INCENTIVE STOCK OPTIONS

July 27, 2021
Rapid Dose Provides Bi-Weekly Status Report Regarding Management Cease Trade Order

July 22, 2021
Rapid Dose Therapeutics Announces the Appointment of Advisory Board

July 20, 2021
Rapid Dose Therapeutics and McMaster University Provide Update on COVID-19 Vaccine Research Collaboration with Orally Dissolvable QuickStrip™ Technology

July 14, 2021
Rapid Dose Provides Bi-Weekly Status Report Regarding Management Cease Trade Order and Update Regarding Interim Financial Statements

July 13, 2021
Rapid Dose Therapeutics-Branded Cannabis Products in Retail Locations Across Canada Via Master Distribution Agreement with Namaste Technologies Subsidiary CannMart

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16